After receipt of an application, FDA will:

1. (a) Refuse to accept the application as described in § 1114.27(a);
2. (b) Issue a letter administratively closing the application;
3. (c) Issue a letter canceling the application if FDA finds that it mistakenly accepted the application or that the application was submitted in error;
4. (d) Refuse to file the application as described in § 1114.27(b);
5. (e) Issue a marketing granted order as described in § 1114.31; or
6. (f) Issue a marketing denial order as described in § 1114.33.